Resmed Financial Statements From 2010 to 2025

Stocks . Australia . 
Stock . Resmed Inc DRC
RMD Stock   38.85  0.50  1.30%   
Resmed financial statements provide useful quarterly and yearly information to potential Resmed Inc DRC investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Resmed financial statements helps investors assess Resmed's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Resmed's valuation are summarized below:
Gross Profit
2.8 B
Profit Margin
0.2315
Market Capitalization
57.1 B
Enterprise Value Revenue
7.4098
Revenue
4.8 B
There are currently ninety-three trending fundamental ratios for Resmed Inc DRC that can be evaluated and compared over time across competitors. All traders should check out Resmed's recent fundamentals against the performance from 2010 to 2025 and make sure the trends continue to evolve in the right direction.

Resmed Total Revenue

5.66 Billion

Check Resmed financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Resmed's main balance sheet or income statement drivers, such as Depreciation And Amortization of 261.1 M, Total Revenue of 5.7 B or Gross Profit of 3.2 B, as well as many indicators such as . Resmed financial statements analysis is a perfect complement when working with Resmed Valuation or Volatility modules.
  
This module can also supplement various Resmed Technical models . Check out the analysis of Resmed Correlation against competitors.

Resmed Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets8.3 B7.9 B4.2 B
Slightly volatile
Short and Long Term Debt Total1.1 B1 B793.7 M
Slightly volatile
Total Current Liabilities1.1 B1 B590.7 M
Slightly volatile
Total Stockholder Equity5.9 B5.6 B2.7 B
Slightly volatile
Property Plant And Equipment Net844.2 M804 M499.5 M
Slightly volatile
Retained Earnings6 B5.7 B2.9 B
Slightly volatile
Accounts Payable287.1 M273.4 M131.4 M
Slightly volatile
Cash333.5 M274.1 M456.6 M
Slightly volatile
Non Current Assets Total5.5 B5.2 B2.5 B
Slightly volatile
Non Currrent Assets Other588.7 M560.7 M219.4 M
Slightly volatile
Cash And Short Term Investments338 M274.1 M456.9 M
Slightly volatile
Net Receivables1 B962.9 M516.9 M
Slightly volatile
Common Stock Shares Outstanding161.2 M169.7 M1.1 B
Slightly volatile
Liabilities And Stockholders Equity8.3 B7.9 B4.2 B
Slightly volatile
Non Current Liabilities Total1.3 B1.3 B876.7 M
Slightly volatile
Inventory992.9 M945.6 M451.3 M
Slightly volatile
Other Current Assets555.2 M528.8 M239.4 M
Slightly volatile
Total Liabilities2.4 B2.3 B1.5 B
Slightly volatile
Total Current Assets2.8 B2.7 B1.7 B
Slightly volatile
Short Term Debt66.5 M40.5 M80.1 M
Pretty Stable
Intangible Assets586.7 M558.8 M304.1 M
Slightly volatile
Short Term Investments13.6 M14.3 M34.8 M
Slightly volatile
Common Stock443.7 K676.2 K542.9 K
Slightly volatile
Current Deferred Revenue184.2 M175.4 M86.9 M
Slightly volatile
Good Will3.4 B3.3 B1.5 B
Slightly volatile
Other Liabilities380.6 M362.5 M165.6 M
Slightly volatile
Other Assets161.7 M300.5 M141 M
Slightly volatile
Long Term Debt878.4 M801.9 M710.4 M
Slightly volatile
Long Term Investments37.8 M59.9 M38.1 M
Slightly volatile
Short and Long Term Debt8.5 M8.9 M186.1 M
Slightly volatile
Property Plant Equipment527.8 M765.7 M503.8 M
Slightly volatile
Deferred Long Term Liabilities52.1 M77.1 M52.7 M
Slightly volatile
Long Term Debt Total691.8 M688.8 M833.2 M
Pretty Stable
Capital Surpluse1.7 B1.9 B1.5 B
Slightly volatile
Non Current Liabilities Other51 M48.6 M15.2 M
Slightly volatile
Net Invested Capital4.3 B6.4 B3.8 B
Slightly volatile
Cash And Equivalents254.8 M246.3 M389.5 M
Slightly volatile
Net Working Capital1.1 B1.7 B1.2 B
Very volatile
Capital Stock641.7 K676.2 K588.6 K
Slightly volatile
Capital Lease Obligations156 M191.7 M135.3 M
Slightly volatile
Property Plant And Equipment Gross847 M1.6 B697.4 M
Slightly volatile

Resmed Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization261.1 M248.6 M131.9 M
Slightly volatile
Total Revenue5.7 B5.4 B2.8 B
Slightly volatile
Gross Profit3.2 B3.1 B1.6 B
Slightly volatile
Other Operating Expenses4.1 B3.9 B2 B
Slightly volatile
Operating Income1.6 B1.5 B732.3 M
Slightly volatile
EBIT1.6 B1.5 B759.1 M
Slightly volatile
EBITDA1.8 B1.8 B891 M
Slightly volatile
Cost Of Revenue2.5 B2.3 B1.2 B
Slightly volatile
Total Operating Expenses1.6 B1.5 B869.3 M
Slightly volatile
Income Before Tax1.5 B1.5 B713.1 M
Slightly volatile
Net Income1.2 B1.2 B553 M
Slightly volatile
Income Tax Expense294.4 M280.4 M158.3 M
Slightly volatile
Research Development371.3 M353.7 M191.6 M
Slightly volatile
Interest Expense55.2 M52.6 M26.1 M
Slightly volatile
Selling General Administrative709.4 M1.1 B638.1 M
Slightly volatile
Net Income From Continuing Ops590.7 M1.2 B544.2 M
Slightly volatile
Net Income Applicable To Common Shares537.5 M1 B524.3 M
Slightly volatile
Non Recurring37.4 M35.6 M22.6 M
Slightly volatile
Tax Provision182 M280.4 M149.2 M
Slightly volatile
Interest Income36.1 M51.4 M27.8 M
Slightly volatile
Reconciled Depreciation187.5 M248.6 M154.5 M
Slightly volatile

Resmed Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow1.6 B1.5 B581.4 M
Slightly volatile
Begin Period Cash Flow325.3 M262.1 M486.3 M
Slightly volatile
Depreciation261.1 M248.6 M141.9 M
Slightly volatile
Capital Expenditures66.9 M132.1 M87.6 M
Slightly volatile
Total Cash From Operating Activities1.7 B1.6 B673.5 M
Slightly volatile
Net Income1.2 B1.2 B554.8 M
Slightly volatile
End Period Cash Flow333.5 M274.1 M456.6 M
Slightly volatile
Stock Based Compensation96.8 M92.2 M55.8 M
Slightly volatile
Dividends Paid205.5 M324.7 M202.1 M
Slightly volatile
Change To Netincome65.8 M69.4 M53.5 M
Slightly volatile
Issuance Of Capital Stock49.9 M61.1 M42.3 M
Slightly volatile

Resmed Fundamental Market Drivers

Forward Price Earnings26.3158
Cash And Short Term Investments238.4 M

About Resmed Financial Statements

Resmed shareholders use historical fundamental indicators, such as revenue or net income, to determine how well the company is positioned to perform in the future. Although Resmed investors may analyze each financial statement separately, they are all interrelated. The changes in Resmed's assets and liabilities, for example, are also reflected in the revenues and expenses on on Resmed's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last ReportedProjected for Next Year
Current Deferred Revenue175.4 M184.2 M
Total Revenue5.4 B5.7 B
Cost Of Revenue2.3 B2.5 B

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Resmed Stock Analysis

When running Resmed's price analysis, check to measure Resmed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Resmed is operating at the current time. Most of Resmed's value examination focuses on studying past and present price action to predict the probability of Resmed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Resmed's price. Additionally, you may evaluate how the addition of Resmed to your portfolios can decrease your overall portfolio volatility.
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2024 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY